S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nippon Hinyokika Gakkai zasshi 2006/03/10, Vol.97(2), pp.157
Hauptverfasser: Uemura, Hirotsugu, Uejima, Shigeya, Fujimoto, Kiyohide, Tanaka, Motoyoshi, Hirao, Yoshihiko, Yoshikawa, Kazuhiro
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 157
container_title Nippon Hinyokika Gakkai zasshi
container_volume 97
creator Uemura, Hirotsugu
Uejima, Shigeya
Fujimoto, Kiyohide
Tanaka, Motoyoshi
Hirao, Yoshihiko
Yoshikawa, Kazuhiro
description
doi_str_mv 10.5980/jpnjurol.97.157
format Article
fullrecord <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5980_jpnjurol_97_157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_jpnjurol_97_2_97_KJ00004460008_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2167-5cdffa9229fb600c3c66f097d97345db7c002553a0371cf40a0f55f8a4da8d573</originalsourceid><addsrcrecordid>eNpVkE1OHDEQhS2USJkQ1mxrmSx6sNvtcXvZavGXTBQJyLpVuG3Go_6TbUDsOABcictwkbghEMWLslV67yvXI2Sf0aVQJT3YTsP22o_dUsklE3KHLFhZFplkjH4gC0pzlom8lJ_I5xC2lHLFJV-Qp3OVcahg2mAw2SlE77CD0UJdKZjMFF1r4Aa1doMJ4AY4WVdZlRcwjcFFd2NgwujMEAPcuriB3kQMMbU0eDMklDZdKugTYOzx6_ldPzuve1DP9w9nRicrXCRpOw9ND4z93LKjh5__WGcvrHpm1W-s5_vHb1_IR4tdMHt_713y--jwoj7J1r-OT-tqnemcrWQmdGstqjxX9nJFqeZ6tbJUyVZJXoj2UuqUjxAcKZdM24IitULYEosWy1ZIvksOXrnajyF4Y5vJux79XcNoM8ffvMXfKNmwF8f61bFNK1yZdz36tE9n_tPnc_nxnaZTFOl_tHyX6Q36xgz8DxxLmT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Uemura, Hirotsugu ; Uejima, Shigeya ; Fujimoto, Kiyohide ; Tanaka, Motoyoshi ; Hirao, Yoshihiko ; Yoshikawa, Kazuhiro</creator><creatorcontrib>Uemura, Hirotsugu ; Uejima, Shigeya ; Fujimoto, Kiyohide ; Tanaka, Motoyoshi ; Hirao, Yoshihiko ; Yoshikawa, Kazuhiro</creatorcontrib><identifier>ISSN: 0021-5287</identifier><identifier>EISSN: 1884-7110</identifier><identifier>DOI: 10.5980/jpnjurol.97.157</identifier><language>eng</language><publisher>THE JAPANESE UROLOGICAL ASSOCIATION</publisher><ispartof>The Japanese Journal of Urology, 2006/03/10, Vol.97(2), pp.157</ispartof><rights>2006 Japanese Urological Association</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Uemura, Hirotsugu</creatorcontrib><creatorcontrib>Uejima, Shigeya</creatorcontrib><creatorcontrib>Fujimoto, Kiyohide</creatorcontrib><creatorcontrib>Tanaka, Motoyoshi</creatorcontrib><creatorcontrib>Hirao, Yoshihiko</creatorcontrib><creatorcontrib>Yoshikawa, Kazuhiro</creatorcontrib><title>S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)</title><title>Nippon Hinyokika Gakkai zasshi</title><addtitle>Jpn. j. urol</addtitle><issn>0021-5287</issn><issn>1884-7110</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpVkE1OHDEQhS2USJkQ1mxrmSx6sNvtcXvZavGXTBQJyLpVuG3Go_6TbUDsOABcictwkbghEMWLslV67yvXI2Sf0aVQJT3YTsP22o_dUsklE3KHLFhZFplkjH4gC0pzlom8lJ_I5xC2lHLFJV-Qp3OVcahg2mAw2SlE77CD0UJdKZjMFF1r4Aa1doMJ4AY4WVdZlRcwjcFFd2NgwujMEAPcuriB3kQMMbU0eDMklDZdKugTYOzx6_ldPzuve1DP9w9nRicrXCRpOw9ND4z93LKjh5__WGcvrHpm1W-s5_vHb1_IR4tdMHt_713y--jwoj7J1r-OT-tqnemcrWQmdGstqjxX9nJFqeZ6tbJUyVZJXoj2UuqUjxAcKZdM24IitULYEosWy1ZIvksOXrnajyF4Y5vJux79XcNoM8ffvMXfKNmwF8f61bFNK1yZdz36tE9n_tPnc_nxnaZTFOl_tHyX6Q36xgz8DxxLmT0</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Uemura, Hirotsugu</creator><creator>Uejima, Shigeya</creator><creator>Fujimoto, Kiyohide</creator><creator>Tanaka, Motoyoshi</creator><creator>Hirao, Yoshihiko</creator><creator>Yoshikawa, Kazuhiro</creator><general>THE JAPANESE UROLOGICAL ASSOCIATION</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2006</creationdate><title>S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)</title><author>Uemura, Hirotsugu ; Uejima, Shigeya ; Fujimoto, Kiyohide ; Tanaka, Motoyoshi ; Hirao, Yoshihiko ; Yoshikawa, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2167-5cdffa9229fb600c3c66f097d97345db7c002553a0371cf40a0f55f8a4da8d573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Uemura, Hirotsugu</creatorcontrib><creatorcontrib>Uejima, Shigeya</creatorcontrib><creatorcontrib>Fujimoto, Kiyohide</creatorcontrib><creatorcontrib>Tanaka, Motoyoshi</creatorcontrib><creatorcontrib>Hirao, Yoshihiko</creatorcontrib><creatorcontrib>Yoshikawa, Kazuhiro</creatorcontrib><collection>CrossRef</collection><jtitle>Nippon Hinyokika Gakkai zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uemura, Hirotsugu</au><au>Uejima, Shigeya</au><au>Fujimoto, Kiyohide</au><au>Tanaka, Motoyoshi</au><au>Hirao, Yoshihiko</au><au>Yoshikawa, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)</atitle><jtitle>Nippon Hinyokika Gakkai zasshi</jtitle><addtitle>Jpn. j. urol</addtitle><date>2006</date><risdate>2006</risdate><volume>97</volume><issue>2</issue><spage>157</spage><pages>157-</pages><issn>0021-5287</issn><eissn>1884-7110</eissn><pub>THE JAPANESE UROLOGICAL ASSOCIATION</pub><doi>10.5980/jpnjurol.97.157</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-5287
ispartof The Japanese Journal of Urology, 2006/03/10, Vol.97(2), pp.157
issn 0021-5287
1884-7110
language eng
recordid cdi_crossref_primary_10_5980_jpnjurol_97_157
source EZB-FREE-00999 freely available EZB journals
title S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A21%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S9-3%20A%20phase-I%20trial%20of%20CA9%20peptide%20vaccines%20in%20HLA-A24%20positive%20patients%20with%20metastatic%20renal%20cell%20carcinoma(Symposium%209%E3%80%8CRecent%20Trend%20of%20Treatment%20for%20Metastatic%20Renal%20Cell%20Carcinoma%E3%80%8D)&rft.jtitle=Nippon%20Hinyokika%20Gakkai%20zasshi&rft.au=Uemura,%20Hirotsugu&rft.date=2006&rft.volume=97&rft.issue=2&rft.spage=157&rft.pages=157-&rft.issn=0021-5287&rft.eissn=1884-7110&rft_id=info:doi/10.5980/jpnjurol.97.157&rft_dat=%3Cjstage_cross%3Earticle_jpnjurol_97_2_97_KJ00004460008_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true